FDA Webview
X
about-us-banner

FDA Related News

Home / Articles / FDA Related News
Human Drugs

FDA Sued Over Human Subject Protections

The Center for Responsible Science asks a federal court to order FDA to grant its 2014 petition seeking improvements in clinical trial human subject p...

Human Drugs

Consultants See Industry Gains in FDA Quality Plan

Paragon Consulting says businesses that invest now in a quality approach that fits with the FDA Quality Metrics Initiative can reap business as well a...

Medical Devices

CDRH Webinar Explains 2 De Novo Guidances

A CDRH Webinar describes elements in one final guidance and one draft guidance relating to the de novo classification program.

Human Drugs

Gottlieb Boosts New Drug Approvals, Continuous Mfg.

FDA commissioner Scott Gottlieb assures Congress that the timely implementation of the 21st Century Cures Act is one of the agencys highest priorities...

Human Drugs

Patients Should Benefit from Drug Discounts: PhRMA

A PhRMA report traces how money moves through the pharmaceutical distribution system and suggests that patients should get more of the benefits from n...

Federal Register

Draft Guide on Dual 510(k) and CLIA Waiver

Federal Register notice: FDA makes available a draft guidance entitled Recommendations for Dual 510(k) and Clinical Laboratory Improvement Amendments ...

Federal Register

Public Hearing on Evaluating Nicotine Replacement Products

Federal Register notice: FDA announces a 1/26/2018 public hearing on its approach to evaluating the safety and efficacy of nicotine replacement therap...

Medical Devices

Webinar Stresses Streamlined Approach to Digital Health

CDRH associate director for digital health Bakul Patel tells a webinar on precertification that the goal is a streamlined regulatory approach for soft...

Human Drugs

FDA OKs Earhook Addition to Advanced Bionics Sound Processor

FDA approves an Advanced Bionics PMA supplement to add an acoustic earhook for its the Nada CI Q90 sound processor that transforms the device into a c...

Human Drugs

FDA Worries More About Companies Than Patients: Professor

Journalism professor Charles Seife details ways in which he says FDA is withholding information about Sareptas Exondys 51 to protect the company.